Coherus Oncology, Inc.
CHRS
$1.61
$0.031.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.94% | -- | -- | -11.58% | -371.55% |
| Total Depreciation and Amortization | -7.25% | -- | -- | 1.26% | -33.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 128.97% | -- | -- | -20.63% | 172.29% |
| Change in Net Operating Assets | 274.03% | -- | -- | -80.09% | 188.64% |
| Cash from Operations | 57.45% | -- | -- | -190.28% | 146.13% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.78% | -- | -- | -3,126.20% | -222.07% |
| Cash from Investing | 95.78% | -- | -- | -3,126.20% | -222.07% |
| Total Debt Issued | -- | -- | -- | -- | 100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 100.00% | -- | -- | -2,540.00% | 0.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 340.00% | -- | -- | -- | 100.00% |
| Cash from Financing | 403,950.00% | -- | -- | -214.29% | 238.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 87.26% | -- | -- | -254.00% | 145.83% |